Tumor markers licensed to strategical partners

Arocell is constantly building partnerships for establishing projects and developing new products to expand its portfolio.

Established Global Partner

IDL Biotech’s tumor markers (TPS®, MonoTotal®, UBC®, and TPAcyk™) have successfully been out-licensed to Beckman Coulter.

Alliance Partner In China

A strategic partnership with Zecen Biotech has been established for the development of tumor marker on fully automated chemiluminescence immunoassay (CLIA) platforms.

About us

We provide knowledge to decision.

AroCell is a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.

Investors

We are listed on NASDAQ First North Growth Market.

We want to be the obvious choice within our segment in the markets where we are established. The market for our products is large and we are a smaller player with significant growth potential so far. AroCell is unique for a company of this size.